Brussels-based Axiles Bionics Secures First €6M Of Its €8M Series A Round

The round was led and structured by PE Group, with participation from the EIC Fund, Finance&Invest.brussels, private investors, entrepreneurs, and the company’s own management team.

The funding will support the international expansion of Lunaris, which Axiles Bionics describes as the most advanced biomimetic prosthetic foot. Lunaris blends mechanical adaptability with smart embedded systems and is already being used in clinical settings across several countries.

Read Also - Swedish Norrsken Foundation commits €300 Million To Support European Startups

The investment will also help accelerate development of next-generation bionic devices. Axiles Bionics continues to receive strong backing from Innoviris, Brussels’ public agency for research and innovation.

Stefan Yee, founder and CEO of PE Group, says, “Axiles Bionics is setting a new benchmark in robotic prosthetics. With Lunaris already demonstrating clinical, regulatory and initial commercial success, and a disruptive bionic technology on the horizon, Axiles is well-positioned to scale globally and transform the quality of life for amputees worldwide.”

Founded in 2019, Axiles Bionics develops cutting-edge technologies that combine robotics, AI, and biomechanics to improve mobility through advanced prosthetics.

Their first product, Lunaris, is a robotic foot certified by both the FDA and CE, designed to mimic natural walking patterns.

Lunaris marks a new direction in prosthetic technology, built to offer better mobility, responsiveness and comfort for people with lower limb amputations. It also lays the foundation for the company’s future innovations in the field.

Clinical use of Lunaris is steadily growing, driven by increasing interest from both patients and healthcare professionals looking for more advanced alternatives to traditional prosthetics.

Svetoslava Georgieva, Chair of the European Innovation Council (EIC) Fund Board, says, “The EIC Fund is proud to participate in this funding round, supporting a European deeptech company that has already demonstrated impressive commercial success and clinical achievements.”

“Axiles Bionics exemplifies the kind of science-driven innovation Europe needs to stay globally competitive in health technology and human-centric robotics.

Pierre Cherelle, founder and CEO of Axiles Bionics, adds, “We envision a future where advanced bionics become standard, enhancing lives with superior mobility, health, and wellbeing. This funding is a vote of confidence in our vision, our team, and the patients we serve.”

“Lunaris has proven that intuitive, lifelike mobility is achievable today. With our pipeline of bionic technologies, we aim to raise the bar once more — and reshape the global standard of prosthetic technology.”

PE Group is an evergreen private equity fund founded by Stefan Yee, backed by the Van Rompay family and other investors. It manages €125 million and leads PE Capital Group (PECG), a closed-end fund structured as a Belgian privak/pricaf. Both funds invest in mid-sized Belgian companies across various sectors.

The European Innovation Council (EIC) Fund, set up by the European Commission, backs companies across all EU countries and sectors, including those tied to Horizon Europe. It provides the equity portion of the EIC Accelerator’s blended finance, with the European Investment Bank acting as its advisor. The EIC Fund aims to close financing gaps, support disruptive tech, and encourage private investment. It also focuses on female founders and reducing the innovation divide within the EU.

Finance&Invest.brussels is a public company that helps Brussels-based businesses grow by offering tailored financing options. It supports sectors that drive economic growth and job creation through loans, equity, and guarantees for startups, SMEs, social enterprises, and cooperatives. Its goal is to fill financing gaps and bring in private investors to strengthen the local entrepreneurial ecosystem.

About Axiles Bionics

Founded in 2018, Axiles Bionics is a Brussels-based spin-off from Vrije Universiteit Brussel, focused on developing the next generation of robotic ankle-foot prosthetics. The company’s mission is simple: to improve the quality of life for amputees by bringing its advanced bionic foot to market.